AXP vs KPTI · P/E 20, rev $21.73B vs rev $68.5M
American Express Company (AXP) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the AXP and KPTI stock pages for the full models.
Not investment advice.